Alzheimer’s Screening and Prevention Act of 2025 provides Medicare coverage for blood-based dementia screening tests.
The Alzheimer’s Screening and Prevention Act of 2025 amends title XVIII of the Social Security Act to include coverage for blood-based dementia screening tests under Medicare. This includes tests for the early detection of Alzheimer’s disease and related dementias. The bill defines these tests as those cleared under the Federal Food, Drug, and Cosmetic Act and furnished to individuals starting from January 1, 2028. The coverage aims to facilitate early detection and intervention for Alzheimer’s disease and related dementias.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.